Glaxo's Wellbutrin/Zyban U.S. Half-Year Sales More Than Double To $325 Mil.
Executive Summary
U.S. sales for Glaxo Wellcome's bupropion formulations Wellbutrin and Zyban more than doubled in the first half to $325 mil., the firm reported at a press conference in London July 30.